eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Novo Nordisk Limited
Broadfield Park, Brighton Road, Crawley, West Sussex, RH11 9RT
Telephone: +44 (0)1293 613555
Fax: +44 (0)1293 613535
Medical Information Direct Line: +44 (0)845 600 5055
Medical Information e-mail: ukmedicalinfo@novonordisk.com
Customer Care direct line: +44 (0)845 600 5055
Medical Information Fax: +44 (0)1293 613211

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 22/06/2011
PIL Kliofem

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
Updated on 24/06/2010 and displayed until 22/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 23/03/2010 and displayed until 24/06/2010
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to how the medicine works
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 16/05/2007 and displayed until 23/03/2010
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change of inactive ingredient
Updated on 22/09/2006 and displayed until 16/05/2007
Reasons for adding or updating:
  • Extra statutory information
Updated on 10/01/2006 and displayed until 22/09/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to side-effects
Updated on 28/04/2005 and displayed until 10/01/2006
Reasons for adding or updating:
  • Change in co-marketing arrangement
Updated on 24/01/2002 and displayed until 28/04/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 02/08/2000 and displayed until 24/01/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  estradiol hemihydrate
  norethisterone acetate